• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉胰岛素输注电子算法的中介变量和算法参数

Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion.

作者信息

Braithwaite Susan S, Godara Hemant, Song Julie, Cairns Bruce A, Jones Samuel W, Umpierrez Guillermo E

机构信息

University of Illinois Chicago, Chicago, Illinois 60202, USA.

出版信息

J Diabetes Sci Technol. 2009 Jul 1;3(4):835-56. doi: 10.1177/193229680900300432.

DOI:10.1177/193229680900300432
PMID:20144334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2769966/
Abstract

BACKGROUND

Algorithms for intravenous insulin infusion may assign the infusion rate (IR) by a two-step process. First, the previous insulin infusion rate (IR(previous)) and the rate of change of blood glucose (BG) from the previous iteration of the algorithm are used to estimate the maintenance rate (MR) of insulin infusion. Second, the insulin IR for the next iteration (IR(next)) is assigned to be commensurate with the MR and the distance of the current blood glucose (BG(current)) from target. With use of a specific set of algorithm parameter values, a family of iso-MR curves is created, each giving IR as a function of MR and BG.

METHOD

To test the feasibility of estimating MR from the IR(previous) and the previous rate of change of BG, historical hyperglycemic data points were used to compute the "maintenance rate cross step next estimate" (MR(csne)). Historical cases had been treated with intravenous insulin infusion using a tabular protocol that estimated MR according to column-change rules. The mean IR on historical stable intervals (MR(true)), an estimate of the biologic value of MR, was compared to MR(csne) during the hyperglycemic iteration immediately preceding the stable interval. Hypothetically calculated MR(csne)-dependent IR(next) was compared to IR(next) assigned historically. An expanded theory of an algorithm is developed mathematically. Practical recommendations for computerization are proposed.

RESULTS

The MR(true) determined on each of 30 stable intervals and the MR(csne) during the immediately preceding hyperglycemic iteration differed, having medians with interquartile ranges 2.7 (1.2-3.7) and 3.2 (1.5-4.6) units/h, respectively. However, these estimates of MR were strongly correlated (R(2) = 0.88). During hyperglycemia at 941 time points the IR(next) assigned historically and the hypothetically calculated MR(csne)-dependent IR(next) differed, having medians with interquartile ranges 4.0 (3.0-6.0) and 4.6 (3.0-6.8) units/h, respectively, but these paired values again were correlated (R(2) = 0.87). This article describes a programmable algorithm for intravenous insulin infusion. The fundamental equation of the algorithm gives the relationship among IR; the biologic parameter MR; and two variables expressing an instantaneous rate of change of BG, one of which must be zero at any given point in time and the other positive, negative, or zero, namely the rate of change of BG from below target (rate of ascent) and the rate of change of BG from above target (rate of descent). In addition to user-definable parameters, three special algorithm parameters discoverable in nature are described: the maximum rate of the spontaneous ascent of blood glucose during nonhypoglycemia, the glucose per daily dose of insulin exogenously mediated, and the MR at given patient time points. User-assignable parameters will facilitate adaptation to different patient populations.

CONCLUSIONS

An algorithm is described that estimates MR prior to the attainment of euglycemia and computes MR-dependent values for IR(next). Design features address glycemic variability, promote safety with respect to hypoglycemia, and define a method for specifying glycemic targets that are allowed to differ according to patient condition.

摘要

背景

静脉输注胰岛素的算法可能通过两步过程来确定输注速率(IR)。首先,利用先前的胰岛素输注速率(IR(previous))和算法上一次迭代时血糖(BG)的变化速率来估算胰岛素输注的维持速率(MR)。其次,将下一次迭代的胰岛素IR(IR(next))设定为与MR以及当前血糖(BG(current))与目标值的差距相匹配。通过使用一组特定的算法参数值,创建了一族等MR曲线,每条曲线都将IR表示为MR和BG的函数。

方法

为了测试从IR(previous)和先前的BG变化速率估算MR的可行性,利用历史高血糖数据点来计算“维持速率跨步下一次估计值”(MR(csne))。历史病例采用表格方案进行静脉胰岛素输注治疗,该方案根据列变化规则估算MR。将历史稳定期的平均IR(MR(true))(对MR生物学值的一种估计)与稳定期之前高血糖迭代期间的MR(csne)进行比较。将假设计算的依赖于MR(csne)的IR(next)与历史上分配的IR(next)进行比较。从数学上推导出一种扩展的算法理论。提出了计算机化的实用建议。

结果

在30个稳定期各自确定的MR(true)与紧接在前的高血糖迭代期间的MR(csne)有所不同,中位数及其四分位间距分别为2.7(1.2 - 3.7)和3.2(1.5 - 4.6)单位/小时。然而,这些MR估计值具有很强的相关性(R² = 0.88)。在941个高血糖时间点,历史上分配的IR(next)与假设计算的依赖于MR(csne)的IR(next)有所不同,中位数及其四分位间距分别为4.0(3.0 - 6.0)和4.6(3.0 - 6.8)单位/小时,但这些配对值再次具有相关性(R² = 0.87)。本文描述了一种用于静脉胰岛素输注的可编程算法。该算法的基本方程给出了IR、生物学参数MR以及表示BG瞬时变化速率的两个变量之间的关系,其中一个变量在任何给定时间点必须为零,另一个为正、负或零,即低于目标值时的BG变化速率(上升速率)和高于目标值时的BG变化速率(下降速率)。除了用户可定义的参数外,还描述了三个在自然界中可发现的特殊算法参数:非低血糖期间血糖的最大自发上升速率、外源性介导的每单位胰岛素剂量对应的葡萄糖量以及给定患者时间点的MR。用户可分配的参数将有助于适应不同的患者群体。

结论

描述了一种在达到正常血糖之前估算MR并计算依赖于MR的IR(next)值的算法。设计特点考虑了血糖变异性,提高了低血糖方面的安全性,并定义了一种根据患者情况允许设定不同血糖目标的方法。

相似文献

1
Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion.静脉胰岛素输注电子算法的中介变量和算法参数
J Diabetes Sci Technol. 2009 Jul 1;3(4):835-56. doi: 10.1177/193229680900300432.
2
Algorithms for intravenous insulin delivery.静脉注射胰岛素给药算法。
Curr Diabetes Rev. 2008 Aug;4(3):258-68. doi: 10.2174/157339908785294451.
3
Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.创伤服务重症监护病房入院患者中剂量确定胰岛素输注方案的实施情况。
Diabetes Technol Ther. 2006 Aug;8(4):476-88. doi: 10.1089/dia.2006.8.476.
4
Target attainment through algorithm design during intravenous insulin infusion.静脉输注胰岛素期间通过算法设计实现目标达成。
Diabetes Technol Ther. 2014 Apr;16(4):208-18. doi: 10.1089/dia.2013.0287. Epub 2013 Dec 19.
5
A quadruply-asymmetric sigmoid to describe the insulin-glucose relationship during intravenous insulin infusion.采用四重非对称 S 型描述静脉内胰岛素输注期间的胰岛素-葡萄糖关系。
J Healthc Eng. 2014;5(1):23-53. doi: 10.1260/2040-2295.5.1.23.
6
Hypoglycemia Prevention by Algorithm Design During Intravenous Insulin Infusion.静脉输注胰岛素时通过算法设计预防低血糖
Curr Diab Rep. 2018 Mar 26;18(5):26. doi: 10.1007/s11892-018-0994-4.
7
Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.连续性静脉输注胰岛素和专门的营养支持期间与肾衰竭相关的低血糖增加。
Nutrition. 2011 Jul-Aug;27(7-8):766-72. doi: 10.1016/j.nut.2010.08.009. Epub 2010 Oct 25.
8
Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study.前瞻性评估一种用于非危重症糖尿病患者的动态胰岛素输注算法:一项前后研究。
PLoS One. 2019 Jan 28;14(1):e0211425. doi: 10.1371/journal.pone.0211425. eCollection 2019.
9
Evaluation of nursing adherence to a paper-based graduated continuous intravenous regular human insulin infusion algorithm.评估纸质版连续性静脉输注常规人胰岛素输注算法的护理依从性。
Nutrition. 2012 Oct;28(10):1008-11. doi: 10.1016/j.nut.2012.01.010. Epub 2012 May 31.
10
Hyperglycemia during acute coronary syndrome: a nurse-managed insulin infusion protocol for stricter and safer control.急性冠状动脉综合征期间的高血糖:一种由护士管理的胰岛素输注方案,用于更严格、更安全的控制。
Eur J Cardiovasc Nurs. 2009 Sep;8(3):182-9. doi: 10.1016/j.ejcnurse.2008.12.001. Epub 2009 Jan 29.

引用本文的文献

1
An evaluation of "I, Pancreas" algorithm performance in silico.“我,胰腺”算法在计算机模拟中的性能评估。
J Diabetes Sci Technol. 2009 Jul 1;3(4):857-62. doi: 10.1177/193229680900300433.

本文引用的文献

1
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.美国临床内分泌医师协会与美国糖尿病协会关于住院患者血糖控制的共识声明。
Diabetes Care. 2009 Jun;32(6):1119-31. doi: 10.2337/dc09-9029. Epub 2009 May 8.
2
Intensive versus conventional glucose control in critically ill patients.危重症患者强化血糖控制与常规血糖控制的比较
N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24.
3
Algorithms for intravenous insulin delivery.静脉注射胰岛素给药算法。
Curr Diabetes Rev. 2008 Aug;4(3):258-68. doi: 10.2174/157339908785294451.
4
A replicable method for blood glucose control in critically Ill patients.一种用于危重症患者血糖控制的可重复方法。
Crit Care Med. 2008 Jun;36(6):1787-95. doi: 10.1097/CCM.0b013e3181743a5a.
5
Intensive blood glucose control in acute and prolonged critical illness: endogenous secretion contributes more to plasma insulin than exogenous insulin infusion.急性和长期危重症中的强化血糖控制:内源性分泌对血浆胰岛素的贡献大于外源性胰岛素输注。
Metabolism. 2008 May;57(5):669-71. doi: 10.1016/j.metabol.2008.01.001.
6
Inpatient insulin therapy.住院患者胰岛素治疗
Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):159-66. doi: 10.1097/MED.0b013e3282f827e7.
7
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.急性心肌梗死住院患者的血糖监测:确定基于最佳结局的风险衡量指标。
Circulation. 2008 Feb 26;117(8):1018-27. doi: 10.1161/CIRCULATIONAHA.107.740498. Epub 2008 Feb 11.
8
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.严重脓毒症的强化胰岛素治疗与羟乙基淀粉复苏
N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716.
9
Tight glycemic control in critically injured trauma patients.危重伤病员的严格血糖控制
Ann Surg. 2007 Oct;246(4):605-10; discussion 610-2. doi: 10.1097/SLA.0b013e318155a789.
10
Severe hypoglycemia in critically ill patients: risk factors and outcomes.危重症患者的严重低血糖:危险因素与结局
Crit Care Med. 2007 Oct;35(10):2262-7. doi: 10.1097/01.CCM.0000282073.98414.4B.